The Biden administration’s pandemic agenda must not ignore superbugs

  04 March 2021

What if another devastating pandemic came on the heels of Covid-19?

Unfortunately, that looks increasingly possible. For years, the antibiotics used to fight various bacterial infections have grown gradually less effective. If current trends continue, these antibiotics could stop working altogether in the near future, leaving humanity vulnerable to deadly, drug-resistant “superbugs.”

Preventing this public health threat will require an aggressive, federally backed effort to develop new and more potent antibiotics. As the Biden administration begins thinking about pandemic preparedness, it should focus on jump-starting innovation in developing new antimicrobial drugs.

Further reading: Stat News
Author(s): Michelle McMurry-Heath
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed